Kraig Biocraft Laboratories (KBLB) Non-Current Debt (2010 - 2022)

Kraig Biocraft Laboratories has disclosed Non-Current Debt across 9 years of filings, most recently posting $44952.0 for Q3 2022.

• Non-Current Debt for Q3 2022 came in at $44952.0, down 59.22% year-over-year; the trailing twelve-month figure through Sep 2022 was $44952.0 (down 59.22% YoY), and the FY2021 annual result was $95244.0, down 34.42% from the prior year.
• Non-Current Debt came in at $44952.0 for Q3 2022 at Kraig Biocraft Laboratories, down from $59952.0 in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $322000.0 in Q4 2018 to a low of $44952.0 in Q3 2022.
• The 5-year median for Non-Current Debt is $142744.0 (2020), against an average of $150003.2.
• Across the five-year window, Non-Current Debt fell 20.56% in 2021 and plunged 59.22% in 2022, its largest moves.
• Kraig Biocraft Laboratories' Non-Current Debt stood at $322000.0 in 2018, then sank by 42.47% to $185244.0 in 2019, then fell by 21.59% to $145244.0 in 2020, then plunged by 34.42% to $95244.0 in 2021, then tumbled by 52.8% to $44952.0 in 2022.
• The last three Non-Current Debt figures came in at $44952.0 (Q3 2022), $59952.0 (Q2 2022), and $62622.0 (Q1 2022), per Business Quant data.